Infant respiratory distress syndrome
Infant Respiratory Distress Syndrome (IRDS), also known as surfactant deficiency disorder (SDD) or hyaline membrane disease (HMD), is a common breathing disorder in premature infants caused by a lack of surfactant, a substance that keeps the lungs expanded, leading to lung collapse and difficulty breathing. This condition predominantly affects babies born before 28 weeks of pregnancy and may result from developmental insufficiency of surfactant production, structural immaturity of the lungs, neonatal infection, or genetic issues related to surfactant-associated proteins.
Health Outcomes
- Earlier Achievement of Full Feeding
- Improved Apgar Score
- Improved Arterial Oxygen Partial Pressure
- Improved Neonatal Health Outcomes
- Improved Oxygen Saturation
- Improved Oxygenation Index
- Increased Neonatal Death
- Increased Risk of Necrotizing Enterocolitis Stage 2 or Higher
- Necrotizing Enterocolitis in Preterm Neonates
- No Impact on Infant Anthropometric Measurements
- Reduced Age at Full Postnatal Feeds
- Reduced Bronchopulmonary Dysplasia
- Reduced Bronchopulmonary Dysplasia Incidence
- Reduced Duration of Mechanical Ventilation
- Reduced Full Feeding Days
- Reduced Milk Aspiration
- Reduced NICU Admission
- Reduced NICU Requirement
- Reduced Necrotizing Enterocolitis Stage II
- Reduced Need for Mechanical Ventilation
- Reduced Neonatal Death
- Reduced Neonatal Mortality
- Reduced Oxygen Requirement
- Reduced Oxygen Saturation Decrease
- Reduced Oxygen Support Requirement
- Reduced Perinatal Mortality
- Reduced Respiratory Distress Syndrome
- Reduced Retinopathy of Prematurity
- Reduced Time to Cessation of Oxygen Support
- Reduced Time to Reach Full Feeds